IL1B and Mental deterioration: Emerging evidence highlights maladaptive microglial activation, chronic cytokine signaling (including IL-1β, TNF-<i>α</i>, and IL-6), and hypothalamic-pituitary-adrenal (HPA) axis hyperactivity as pivotal contributors to neuronal damage and cognitive decline.